Report Presentation Webcast
October 21, 2021 Interview Erik Penser Bank
September 29, 2021 Naventus LifeScience Summit
September 7, 2021 Presentation at Aktiedagen Stockholm
June 11, 2021 Aktiespararna: Interview with Oasmia Pharmaceutical
April 12, 2021 Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting
March 11, 2021 Sachs 14th Annual European Life Sciences CEO Forum, Virtual
March 1, 2021 Oasmia acquires global development and commercialization rights for Cantrixil
February 10, 2021 Swiss Nordic Bio
January 19, 2021 SEB Digital Healthcare Seminar Presentation
December 3, 2020 Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer
November 11, 2020 Investival Showcase 11-16 November 2020, Virtual Conference
29 October, 2020 BIO-Europe®, Virtual Conference
October 7, 2020 Oasmia Erik Penser Cancer Day Presentation
September 24, 2020 Oasmia Erik Penser Investor Event Presentation
September 21, 2020 Presentation at Sachs Biotech in Europe Forum
September 15, 2020 Aktiedagen Digitalt
July 30, 2020 Analysguiden: Interview with Oasmia
June 10, 2020 Company Presentation Aktiespararna
June 3, 2020 Avanza Börsdag
May 13, 2020 Strategic Review Presentation
March 25, 2020 Elevar deal
February 14, 2020 Oasmia appoints new CEO